Linus Biotechnology

Developer of diagnostic tests for central nervous system and gastrointestinal disorders

placeNew York City, New York, United States calendar_todayFounded 2020 groups12 employees language linusbio.com

Innovation

3 patent families — focus: Physics & computing; filing pace accelerating. Cited 27 times.

YearFilings
20232
20242
20253
20261

Social engagement

Social engagement: 2.9K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; lead investors include GreatPoint Ventures, Bow Capital.

Investor typeCountShare
Venture capital360%
Other / undisclosed240%

Recent activity

1 Apr 2026
Event
Frontera's The Future of Autism Care Summit
Coming soon